MDA's 2015 Scientific Conference points the way toward tomorrow's therapies
Last month, MDA brought together more than 400 of the nation’s leading scientists, researchers and professionals specializing in neuromuscular disease research and care at its 2015 Scientific Conference in Washington, D.C., March 11–14. This pre-eminent gathering, hosted every other year, was designed to accelerate discoveries and drug development for families fighting neuromuscular diseases.
“One key strategy to accelerating lifesaving and life-enhancing treatments and cures for neuromuscular and motor neuron diseases is to ensure collaboration among the nation’s top leaders in our scientific community,” said MDA President and CEO Steven M. Derks. “I’m proud that, in addition to the hundreds of different research projects we fund, MDA continues to be a facilitator for researchers nationwide to share ideas, best practices and novel strategies through our scientific and clinical conferences.”
Translating hope into action
This year’s conference focused on better understanding disease causes, identifying potential therapies and discussing new advances in laboratory and clinical research.
Clinicians and scientists who attended were excited about the new developments in disease research and treatment they can take back to their labs and families they serve. MDA anticipates the number of promising human clinical trials will double in the next five years.
Here are some highlights of developments and important topics discussed at the conference, many of which may have spillover implications for multiple disorders:
Read the daily conference updates to learn more about the specific research presented and for more details on the studies discussed.